These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8799402)

  • 1. The role of prostanoid in hepatic damage during hepatectomy.
    Shirabe K; Takenaka K; Yamamoto K; Kitamura M; Itasaka H; Matsumata T; Shimada M; Sugimachi K
    Hepatogastroenterology; 1996; 43(9):596-601. PubMed ID: 8799402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
    Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
    Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
    Kobayashi T; Esato K; Morita N; Noshima NS
    Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of thromboxane A2 synthetase inhibitor (OKY-046) on 24-hr simple hypothermic preservation of the canine pancreas graft.
    Nagami H; Tamura K; Kin S; Teramoto M; Ishida T
    Int Surg; 1995; 80(3):274-7. PubMed ID: 8775620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of prostaglandins and renal function after hepatic resection.
    Matsumata T; Yamamoto K; Shirabe K; Shimada M; Sugimachi K; Takesue F; Muto Y; Ikeda T
    Hepatogastroenterology; 1997; 44(15):774-8. PubMed ID: 9222688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic resection under in situ hypothermic hepatic perfusion.
    Kaiho T; Tanaka T; Tsuchiya S; Yanagisawa S; Takeuchi O; Miura M; Saigusa N; Kitakata Y; Miyazaki M
    Hepatogastroenterology; 2003; 50(51):761-5. PubMed ID: 12828080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury.
    Isozaki H; Okajima K; Hara H; Kobayashi M
    Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats.
    Xu H; Lee CY; Clemens MG; Zhang JX
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e212-20. PubMed ID: 17645480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice.
    Takahashi T
    Surg Today; 1996; 26(1):15-20. PubMed ID: 8680115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a cyclooxygenase-2 inhibitor, FK3311, on total hepatic ischemia-reperfusion injury of the rat.
    Kobayashi M; Takeyoshi I; Kurabayashi M; Matsumoto K; Morishita Y
    Hepatogastroenterology; 2007 Mar; 54(74):522-6. PubMed ID: 17523312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of thromboxane A2 synthetase inhibitor on cold-stored rat liver.
    Suehiro T; Yanaga K; Itasaka H; Kishikawa K; Shirabe K; Sugimachi K
    Transplantation; 1994 Oct; 58(7):768-73. PubMed ID: 7940709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver.
    Kim YI; Chung HJ; Song KE; Hwang YJ; Lee JW; Lee YJ; Chun BY
    Am J Surg; 2006 Jan; 191(1):72-6. PubMed ID: 16399110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tetrodotoxin and OKY-046 in renal ischemia reperfusion.
    Garvin PJ; Niehoff ML; Robinson SM
    J Surg Res; 1999 Aug; 85(2):273-8. PubMed ID: 10423329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine response to human liver ischemia-reperfusion injury during hepatectomy: marker of injury or surgical stress?
    Hanazaki K; Monma T; Hiraguri M; Ohmoto Y; Kajikawa S; Matsushita A; Nimura Y; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2001; 48(37):188-92. PubMed ID: 11268962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
    Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
    J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation.
    Soejima Y; Yanaga K; Nisizaki T; Yoshizumi T; Uchiyama H; Sugimachi K
    Surgery; 1998 Jan; 123(1):67-72. PubMed ID: 9457225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study.
    Azoulay D; Lucidi V; Andreani P; Maggi U; Sebagh M; Ichai P; Lemoine A; Adam R; Castaing D
    J Am Coll Surg; 2006 Feb; 202(2):203-11. PubMed ID: 16427543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a thromboxane synthetase inhibitor (OKY-046) on vascular reactivity to angiotensin II after stricture of the abdominal aorta in pregnant rabbits.
    Ushijima H; Ito M; Yoshimura T; Mabe K; Okamura H
    Artery; 1992; 19(2):63-75. PubMed ID: 1580798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of cytokine production by thromboxane A2 inhibitor in liver ischemia.
    Sugawara Y; Harihara Y; Takayama T; Makuuchi M
    Hepatogastroenterology; 1998; 45(23):1781-6. PubMed ID: 9840148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.